Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice

Recurrent locally advanced or metastatic head and neck squamous cell carcinoma (HNSCC) is associated with dismal prognosis because of its highly invasive behavior and resistance to conventional intensive chemotherapy. The combination of targeted therapy and conventional chemotherapy has significantl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hui-Ching Wang, Tsung-Jang Yeh, Leong-Perng Chan, Chin-Mu Hsu, Shih-Feng Cho
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-10-01
Colecção:International Journal of Molecular Sciences
Assuntos:
head and neck cancer
immunotherapy
immune checkpoint inhibitor
biomarker
Acesso em linha:https://www.mdpi.com/1422-0067/21/20/7621
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados